102650-29-3

Basic information

• Product Name: p-NH2-Bn-DTPA(B-300)
• Synonyms: p-NH2-Bn-DTPA(B-300);p-NH2-Bn-DTPA;S-2-(4-AMinobenzyl)-diethylenetriaMine pentaacetic acid TFA salt, p-NH2-Bn-DTPA-TFA;S-2-(4-AMinobenzyl)-diethylenetriaMine pentaacetic acid TFA salt;p-NH2-Bn-DTPA-TFA;2-(4-AMINOBENZYL)-DIETHYLENETRIAMINEPENTAACETIC ACID;S-2-(4-AMINOBENZYL)-DIETHYLENETRIAMINE PENTAACETIC ACID, 4TFA
• CAS NO: 102650-29-3
• Molecular Formula: C21H30N4O10
• Molecular Weight: 498.4837
• Mol File: 102650-29-3.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: p-NH2-Bn-DTPA(B-300)(CAS DataBase Reference)
• NIST Chemistry Reference: p-NH2-Bn-DTPA(B-300)(102650-29-3)
• EPA Substance Registry System: p-NH2-Bn-DTPA(B-300)(102650-29-3)

Safety Data

• Hazardous Substances Data: 102650-29-3(Hazardous Substances Data)

Usage

Uses

p-NH?-Bn-DTPA, is a bifunctional chelating agent.

Upstream product

• 262855-60-7 tert-butyl 2-[(2-{bis[2-(tert-butoxy)-2-oxoethyl]amino}-3-(4-nitrophenyl)propyl)(2-{bis[2-(tert-butoxy)-2-oxoethyl]amino}ethyl)amino]acetate 

Downstream Products

• 853898-82-5 Pr⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Pr(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-88-1 Eu⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Eu(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-84-7 Nd⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Nd(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-92-7 Dy⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Dy(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-94-9 Ho⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Ho(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-74-5 Gd⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Gd(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853899-02-2 Lu⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Lu(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-96-1 Er⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Er(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-90-5 Tb⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Tb(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-86-9 Sm⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Sm(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853899-00-0 Yb⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Yb(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-98-3 Tm⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Tm(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-76-7 Y⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Y(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 
• 853898-80-3 Ce⁽³⁺⁾*O₂CCH₂N(C₂H₄N(CH₂CO₂)2)CH₂CH(CH₂C₆H₄NH₂)N(CH₂CO₂)2^(5-)*H₂O=[Ce(C₂₁H₂₅N₄O₁₀)(OH₂)]^(2-) 

Relevant articles and documents

SYNTHESIS OF THERAPEUTIC AND DIAGNOSTIC DRUGS CENTERED ON REGIOSELECTIVE AND STEREOSELECTIVE RING OPENING OF AZIRIDINIUM IONS

Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.